登录    
  
首页 > 期刊论文 > 论文摘要
RNA干扰抑制Apollon表达联合川芎嗪可增强白血病细胞对化疗药物的敏感性
         
The expression of Apollon gene silenced by RNA interference combined with ligustrazine intervention may increase the sensitivity of leukemia cells to chemotherapeutic agents

摘    要
目的: 探讨RNA干扰(RNA interference,RNAi)技术沉默凋亡抑制蛋白Apollon基因表达联合中药川芎嗪(tetramethylpyrazine,TMP)能否增强人髓系白血病K562细胞对长春新碱(vincristine,VCR)和柔红霉素(daunorubicin,DNR)的药物敏感性。方法: 依据前期实验筛选出的干扰效果最佳的靶向Apollon的小干扰RNA(small interference RNA,siRNA)片段,构建pGPHI-GFP-Neo-Apollon真核表达载体,应用LipofectAMINETM2000转染白血病K562细胞,G418稳定筛选。采用反转录-PCR(reverse transcriptase PCR,RT-PCR)法和细胞免疫荧光法分别检测重组载体稳定转染K562细胞后Apollon mRNA及其蛋白的表达情况;RNAi 联合TMP与VCR或DNR用药后,应用MTT法检测细胞对化疗药物敏感性的变化,FCM法检测细胞凋亡率。结果: 成功构建了pGPHI-GFP-Neo-Apollon载体并在K562细胞内稳定表达,重组载体能有效沉默Apollon mRNA及蛋白表达。RNAi 组细胞联合TMP作用后能明显增加细胞对VCR、DNR的敏感性,其半数抑制浓度(half-inhibitory concentration,IC50)值明显低于单纯TMP作用组(P<0.05),细胞凋亡率也显著增加,与未经任何处理的对照组及单纯TMP作用组比较的凋亡率差异有统计学意义(P<0.05)。结论: 靶向Apollon的RNAi 联合TMP能明显提高K562细胞对VCR、DNR的敏感性,显著减少化疗药物使用剂量且更易于化疗药物诱导细胞凋亡,提示RNAi沉默Apollon基因联合中药TMP能在一定程度上逆转白血病细胞的耐药性。
标    签 白血病   实验性   RNA干扰   凋亡抑制蛋白质类   川芎嗪   抗药性   肿瘤   K562细胞   Leukemia   experimental   RNA interference   Inhibitor of apoptosis proteins   Tetramethylpyrazine   Drug resistance   neoplasm   K562 cells  
 
Abstract
Objective: To investigate whether the expression of Apollon (an apoptosis inhibitory gene) silenced by using RNA interference (RNAi) technology in combination with tetramethylpyrazine (TMP) intervention can increase the sensitivity of human myeloid leukemia K562 cells to vincristine (VCR) and daunorubicin (DNR).Methods: Using the best small interference RNA (siRNA) targeting Apollon gene which was screened out in a previous experiment, the eukaryotic expression vector pGPHI-GFPNeo-Apollon was constructed. Then, the K562 cells were transfected with pGPHI-GFP-Neo-Apollon by LipofectAMINETM 2000 and screened out by G418. After Apollon siRNA was transfected stably into K562 cells, the expressions of Apollon mRNA and protein were detected by reverse transcription (RT)-PCR and immunofluorescence, respectively. The sensitivities to chemotherapeutic agents VCR and DNR after RNAi in combination with TMP intervention were detected by MTT method, and apoptosis rate was detected by flow cytometry.Results: pGPHI-GFP-Neo-Apollon vector was constructed successfully and it could express stably in K562 cells, which silenced the expressions of Apollon mRNA and protein effectively. The sensitivity to VCR or DNR increased significantly after RNAi in combination with TMP intervention. The half inhibitory concentration (IC50) values of VCR and DNR were significantly lower than those in the group of TMP intervention alone (P<0.05). The apoptosis rate of K562 cells after transfection with Apollon siRNA in combination with TMP intervention was significantly increased comparing with that of the untreated control group and TMP intervention alone group (P<0.05).Conclusion: RNAi targeting Apollon gene in combination with TMP intervention can obviously increase the sensitivity to VCR or DNR in K562 cells and significantly reduce the dosage of chemotherapeutic agents as well as improve apoptosis induced by chemotherapy. These results suggest that Apollon gene silenced by RNAi in combination with TMP intervention may reverse the drug resistance of leukemia cells.

中图分类号 R733.7   DOI 10.3781/j.issn.1000-7431.2013.11.006

 
  购买该论文  中国光学期刊网论文下载说明
      


所属栏目 基础研究

基金项目 山东省科学技术发展计划项目(编号:2010GSF10264)

收稿日期 2013/6/26

修改稿日期 2013/9/2

网络出版日期

作者单位点击查看


引用该论文: XIAO Fei-fei,JIA Xiu-hong,LI Jian-chang. The expression of Apollon gene silenced by RNA interference combined with ligustrazine intervention may increase the sensitivity of leukemia cells to chemotherapeutic agents[J]. Tumor, 2013, 33(11): 973~979
孝飞飞,贾秀红,李建厂. RNA干扰抑制Apollon表达联合川芎嗪可增强白血病细胞对化疗药物的敏感性[J]. 肿瘤, 2013, 33(11): 973~979


论文评价
共有人对该论文发表了看法,其中:
人认为该论文很差
人认为该论文较差
人认为该论文一般
人认为该论文较好
人认为该论文很好
分享论文
分享到新浪微博 分享到腾讯微博 分享到人人网 分享到 Google Reader 分享到百度搜藏分享到Twitter

参考文献
【1】LONG J, PARKIN B, OUILLETTE P, et al. Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia[J]. Blood, 2010, 116(1):71-80.
 
【2】WIDMANN C, GERWINS P, JOHNSON N L, et al. MEK kinase1, a substrate for DEVDdirected caspases, is involved in genotoxininduced apoposis[J]. Mol Cell Biol, 1998, 18(4):2416-2429.
 
【3】ISMAIL E A, MAHMOUD H M, TAWFIK L M, et al. BIRC6/Apollon gene expression in childhood acute leukemia:impact on therapeutic response and prognosis[J]. Eur J Haematol, 2012, 88(2):118-127.
 
【4】TASSI E, ZANON M, VEGETTI C, et al. Role of Apollon in human melanoma resistance to antitumor agents that activate the intrinsic or the extrinsic apoptosis pathways[J]. Clin Cancer Res, 2012, 18(12):3316-3327.
 
【5】PENNATI M, MILLO E, GANDELLINI P, et al. RNA Interference-mediated validation of survivin and Apollon/BRUCE as new therapeutic targets for cancer therapy[J]. Curr Top Med Chem, 2012, 12(2):69-78.
 
【6】KELLY K R, ECSEDY J, MEDINA E, et al. The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib[J]. J Cell Mol Med, 2011, 15(10):2057-2070.
 
【7】ÁRVAI K, NAGY K, BARTI-JUHÁSZ H, et al. Molecular profiling of parathyroid hyperplasia, adenoma and carcinoma[J]. Pathol Oncol Res, 2012, 18(3):607-614.
 
【8】张伟, 戴碧涛, 汪明宇, 等. 川芎嗪对白血病细胞Jurkat黏附、运动和侵袭的影响[J]. 重庆医科大学学报, 2008, 33(4):403-406.
 
【9】吴涛, 瞿桂芳. 川芎嗪对白血病K562细胞增殖和凋亡的影响[J]. 中国冶金工业医学杂志, 2010, 27(1):5-7.
 
相关信息
   标题 相关频次
 RNA干扰同源盒A10基因表达可逆转白血病K562细胞多药耐药性
 8
 靶向HOXA9基因RNAi慢病毒载体增加人急性单核细胞白血病U937细胞的药物敏感性
 8
 靶向HOXA9基因RNAi慢病毒载体增加人急性单核细胞白血病U937细胞的药物敏感性
 8
 沉默HOXA10基因表达联合川芎嗪可逆转K562/ADR细胞的多药耐药性
 7
 RNA干扰抑制HOXA7表达能逆转白血病U937细胞多药耐药
 6
 靶向ABCG2基因的RNA干扰提高K562细胞的化疗敏感性
 6
 斑马鱼微肿瘤模型的建立及其在抗血管生成研究中的应用
 6
 As2O3诱导白血病细胞凋亡过程中Ca2+的变化及其调节
 4
 H2O2氧化刺激对紫杉醇耐药和敏感肺癌细胞的不同影响
 4
 RNAi对白血病细胞mdr-1基因和多药耐药表型的影响
 4
 STAT5诱骗寡核苷酸诱导白血病K562细胞凋亡的研究
 4
 Trx-DMLS-AIF融合蛋白的原核表达及其对白血病K562细胞脱细胞系统的影响
 4
 靶向激活蛋白激酶PKR诱导白血病K562细胞凋亡
 4
 长程多柔比星化疗富集乳腺肿瘤干细胞
 4
 川芎嗪对白血病细胞凋亡及凋亡相关蛋白表达的影响
 4
 大黄素诱导裸鼠体内白血病K562细胞凋亡过程中PI3K/AKT通路相关分子表达的变化
 4
 反转录病毒介导的HPV16 E6-siRNA对SiHa细胞增殖及抗药性的影响
 4
 干细胞标志CD90与人肺腺癌A549细胞顺铂耐药之间的关系
 4
 核仁磷酸蛋白和c-Src在耐药肺腺癌细胞中的表达及其与化疗耐药之间的关系
 4
 吉非替尼耐药细胞株的筛选和基因谱表达研究
 4
 结直肠癌奥沙利铂耐药相关蛋白的筛选与鉴定
 4
 人肺腺癌吉非替尼耐药细胞株中微小RNA的表达谱
 4
 上皮-间质转化和胰岛素样生长因子Ⅰ型受体在非小细胞肺癌EGFR-TKIs获得性耐药中的作用
 4
 UHRF1基因沉默对逆转人肺腺癌A549细胞顺铂耐药性的影响
 3
 表皮生长因子受体信号通路与卵巢癌耐药细胞株SKOV3/DDP相关性的研究
 3
 蟾毒灵逆转肺腺癌H1975细胞对吉非替尼耐药的体内实验研究
 3
 急性白血病LRP、mdr1、MRP基因表达的预后意义
 3
 碱基切除修复与抗肿瘤药物耐药
 3
 砷剂作用下大鼠肝癌的形态学及细胞动力学变化
 3
 ABCC8、CHFRBMP3BLOXPRSS21和RASSF1A基因启动子的甲基化状态可能与3种乳腺癌细胞株对5-FU的敏感性相关
 2

  热点专题


关于我们  |   联系我们  |   广告投放  |   《肿瘤》杂志社版权所有 《肿瘤》杂志社   © 中国 上海 2014.3
沪ICP备15036656号-2